Source: MarketScreener

PledPharma AB: Egetis Therapeutics : Corporate presentation, slides

(marketscreener.com) Corporate presentation April 2021 A new specialised late-stage orphan drug development company Disclaimer The information contained in this presentation is strictly confidential. Accordingly, the information included...https://www.marketscreener.com/quote/stock/EGETIS-THERAPEUTICS-AB-P-61747360/news/Egetis-Therapeutics-nbsp-Corporate-presentation-slides-33068859/?utm_medium=RSS&utm_content=20210426

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Nicklas Westerholm

CEO Approval Rating

70/100

Read more